Kennedy Capital Management, Inc. Albireo Pharma, Inc. Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.92 - $28.96 $326,539 - $558,899	-19,299 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$20.0 - $31.88 $28,180 - $44,918	-1,409 Reduced 6.8%	19,299 $386,000
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $16,377 - $20,217	534 Added 2.65%	20,708 $668,000
Q1 2019 May 13, 2019	BUY	$22.22 - $32.21 $448,266 - $649,804	20,174 New	20,174 $650,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.